William Pridgen, Director at Virios Therapeutics, Inc. (VIRI), bought 8,827 shares at $5.66 ($50K) on 2021-12-21, disclosed to the SEC on 2021-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VIRI | BUY | 2022-05-18 | $59K | — | Filing → |
| VIRI | BUY | 2022-03-30 | $3K | — | Filing → |
| VIRI | BUY | 2022-03-24 | $12K | — | Filing → |